• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of Methyl 6-amino-5-hydroxypicolinate (CAS: 1260861-99-1) in Chemical Biology and Pharmaceutical Research

Methyl 6-amino-5-hydroxypicolinate (CAS: 1260861-99-1) has recently emerged as a compound of significant interest in chemical biology and pharmaceutical research. This heterocyclic derivative, characterized by its amino and hydroxyl functional groups, has shown promising potential in various applications, including drug discovery, medicinal chemistry, and biochemical studies. The unique structural features of this compound make it a valuable scaffold for the development of novel therapeutic agents and biochemical probes.

Recent studies have focused on the synthesis and optimization of Methyl 6-amino-5-hydroxypicolinate to enhance its bioavailability and pharmacological properties. Researchers have employed advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and regioselective functionalization, to modify the core structure. These efforts have led to the identification of derivatives with improved solubility, stability, and target-binding affinity, which are critical for their potential therapeutic applications.

In the context of drug discovery, Methyl 6-amino-5-hydroxypicolinate has been investigated as a key intermediate in the synthesis of kinase inhibitors. Kinases play a pivotal role in various cellular signaling pathways, and their dysregulation is associated with numerous diseases, including cancer and inflammatory disorders. Preliminary in vitro studies have demonstrated that derivatives of this compound exhibit inhibitory activity against specific kinase targets, suggesting their potential as lead compounds for further development.

Beyond its role in kinase inhibition, Methyl 6-amino-5-hydroxypicolinate has also been explored for its utility in biochemical assays. The compound's ability to chelate metal ions and participate in hydrogen bonding interactions makes it a versatile tool for studying enzyme mechanisms and protein-ligand interactions. Recent work has highlighted its use in fluorescence-based assays and as a building block for the design of molecular probes.

Despite these promising developments, challenges remain in the optimization of Methyl 6-amino-5-hydroxypicolinate for clinical applications. Issues such as metabolic stability, off-target effects, and formulation compatibility need to be addressed through further research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and unlock the full potential of this compound.

In conclusion, Methyl 6-amino-5-hydroxypicolinate (CAS: 1260861-99-1) represents a promising scaffold in chemical biology and pharmaceutical research. Its unique structural properties and versatile applications make it a valuable candidate for further investigation. Continued research efforts are expected to yield new insights into its mechanisms of action and therapeutic potential, paving the way for innovative treatments in various disease areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)